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Merkel cell carcinoma (MCC) is a rare aggressive neuroendocrine carcinoma of the skin that 
shows locoregional or distant metastasis. Metastasis of MCC to body cavity effusion is extremely 
rare; only three cases have been reported so far. Metastatic MCC in effusion cytology shows 
small blue round cells with fine stippled chromatin like other small blue round cell tumors such as 
small cell lung carcinoma or lymphoma. The diagnosis of metastatic MCC can grant patients 
good chances at recently advanced therapeutic options. Here, we present a case of metastatic 
MCC to pleural effusion with characteristic single file-like pattern.
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▒ CASE STUDY ▒
Merkel cell carcinoma (MCC) is an uncommon aggressive 
neuroendocrine tumor of the skin that occurs primarily in the 
elderly or immunosuppressed individuals and often shows locore-
gional or distant metastasis.1-3 Toker first reported it as “trabec-
ular carcinoma” in 1972,4 however, MCC has not been investi-
gated as actively as other skin tumors due to its rarity and 
uncertain etiology until recently when diagnostic tools including 
immunohistochemistry have improved and polyomavirus has 
been identified to be associated with the tumor.2,5 Although the 
incidence of MCC is increasing and locoregional recurrence or 
metastasis has become common, distant metastases of MCC espe-
cially to body cavity effusions are extremely rare. There are only 
three case reports of metastatic MCC to effusions: two to pleural 
fluid and one to ascites.6-8 Here, we report the first case of meta-
static MCC to pleural effusion in Korea. 
CASE REPORT
This study was approved by the Institutional Review Board 
of Severance Hospital with a waiver of informed consent (IRB 
No. 4-2017-0634).
A 68-year-old female with a medical history of hypertension 
was diagnosed with MCC in the left buttock 2 years ago at an 
outside hospital. The patient underwent excision of the tumor 
with inguinal lymph node dissection. Local recurrence occurred 
after one year, leading to additional left inguinal lymph node 
dissection. According to the positron emission tomography, 
metastases to the regional, intra-abdominal, and right axillary 
lymph nodes were identified. The patient was treated with 
three cycles of etoposide and cisplatin (EP) chemotherapy and 
radiotherapy in the left leg, para-aortic lymph node, and right 
inguinal lymph node. The patient was transferred to our hospital 
due to bone metastasis. Even after five cycles of cyclophospha-
mide, doxorubicin and vincristine (CAV), the disease progressed 
and the patient received first intraperitoneal chemotherapy. The 
patient was admitted to the hospital for fever, diarrhea, poor 
oral intake, and pancytopenia. Metastasis in a small-to-borderline 
sized lymph node in the left axilla and bilateral pleural effusion 
(Fig. 1)  were identified.
Surgically excised specimen stained with hematoxylin and 
eosin presented blue round cell tumor with infiltrative growth, 
showing sheets, clusters, rows or balls of tumor cells with scanty 
cytoplasm, hyperchromatic nuclei, fine stippled or smudged 
chromatin and occasional mitoses (Fig. 2A–D). Immunohisto-
chemical staining showed the tumor cells positive for cytokeratin 
20 (CK20), CD56, chromogranin, and synaptophysin (Fig. 2C, D).
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Liquid based cytology (LBC; SurePath, BD Diagnostics, Bur-
lington, NC, USA) (Fig. 3A) and cell block of pleural effusion 
(Fig. 3B) revealed malignant small blue round cells scattered, 
clustered, or arranged in a single file. Round to oval tumor cells 
showed hyperchromatic nuclei with fine granular salt and pepper 
chromatin, scant cytoplasm, occasional mitotic figures, and occa-
sional nuclear molding (Fig. 3A). Immunohistochemical staining 
on the cell block also showed the tumor cells immunoreactive for 
CK20, CD56, chromogranin, and synaptophysin (Fig. 3C, D).
DISCUSSION
MCC is a rare and highly aggressive skin carcinoma often 
seen in the head and neck region.5 The increasing incidence1,9,10 
and recent new findings about risk factors, especially the identi-
fication of polyomavirus infection,2 stimulated the investigation 
of the etiology, pathogenesis and treatment options.3,5 Although 
Fig. 2. Microscopic findings of the surgical specimen. Blue small round cell tumor with infiltrative growth (A) arranged in sheets, clusters, 
rows or balls, showing hyperchromatic nuclei, fine stippled or smudged chromatin and occasional mitoses (B). Immunohistochemical stain-
ing of cytokeratin 20 (C) and synaptophysin (D) show positive reaction in Merkel cell carcinoma cells.
A
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D
Fig. 1. Chest computed tomography (CT) with cell block findings. 
The chest CT shows marked pleural effusion (arrows).
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most patients present with localized tumors or with locoregional 
metastasis including lymph node metastasis without a primary 
MCC,11 distant metastases have also been reported. According 
to a single institution data, the clinical stage III (positive regional 
lymph node) and IV (distant metastatic disease) were 24% and 
6%, respectively.12 
We reported a rare case of metastatic MCC to pleural effusion 
that had not been reported in Korea before. So far, only two cases 
of pleural metastasis of MCC have been reported worldwide. 
The first case was a metastasis of left great toe MCC to the 
pleural fluid, confirmed by electron microscopy.6 The second 
case was a metastasis of right buttock MCC to the pleural fluid, 
confirmed by immunohistochemical staining of CK20.7 Both 
cases showed small blue round cell clusters with fine granular 
chromatin in the pleural fluid as in our case. MCC stains positive 
for CK20 (a dot-like perinuclear positivity pattern), other epithelial 
markers (AE1/AE3, epithelial membrane antigen, and CAM 
5.2), and neuroendocrine markers (chromogranin, CD56, syn-
aptophysin, and somatostatin).5 We confirmed our diagnosis by 
immunoreactivity of the tumor to CK20, CD56, chromogranin, 
and synaptophysin both in surgical specimen and cytology cell 
block. 
The diagnosis of metastatic MCC to body cavity effusion is easy 
to be missed because of its rarity and similarity of morphology 
to other small round cell tumors. Microscopic findings of the 
pleural effusion cytology of metastatic MCC can be confused 
with metastasis of other malignant neoplasm showing small 
blue round cells: small cell lung carcinoma, lymphoma, malignant 
melanoma, etc. However, immunohistochemical markers such 
as CK20, CD56, chromogranin, and synaptophysin would be 
helpful. 
In this case, multiple single file patterns with cytological 
Fig. 3. (A) Liquid based cytology (BD Surepath) of the pleural effusion (Papanicolaou stain). Malignant small blue round cells are scattered, 
clustered or arranged with hyperchromatic nuclei, fine granular salt and pepper chromatin, scant cytoplasm, and occasional mitotic figures. 
Several single file patterns with nuclear molding are characteristic (arrows). (B) The cell block findings are similar to those in liquid based cy-
tology’s. Immunohistochemical staining of cytokeratin 20 (C) and synaptophysin (D) in the cell block of pleural effusion.
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molding were dominant in both LBC and cell block. This iden-
tification of multiple single file patterns is a novel finding that 
has not been described in previous reports.6,7 It is more charac-
teristic in LBC and may therefore be a helpful cytological clue 
in the era of LBC. The detection of hidden MCC presented only 
as distant metastasis in effusion could give patients good chances 
at cure because therapeutic options for MCC have increased 
recently: chemotherapy, immunotherapy, radiotherapy and tar-
geted therapy.13 
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